当前位置: X-MOL 学术Diabetes › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Engineering a Pathway to Glucose-Responsive Therapeutics
Diabetes ( IF 7.7 ) Pub Date : 2024-04-12 , DOI: 10.2337/dbi23-0029
Matthew J. Webber 1
Affiliation  

In 2014, the American Diabetes Association instituted a novel funding paradigm to support diabetes research through its Pathway to Stop Diabetes® Program. Pathway took a multifaceted approach to provide key funding to diabetes researchers in advancing a broad spectrum of research programs centered on all aspects of understanding, managing, and treating diabetes. Herein the personal perspective of a 2019 Pathway Accelerator awardee is offered, describing a research program seeking to advance a materials-centered approach to engineering glucose-responsive devices and new delivery tools for better therapeutic outcomes in treating diabetes. This is offered alongside a personal reflection on five years of support from the ADA Pathway Program.

中文翻译:

设计一条葡萄糖反应性治疗途径

2014 年,美国糖尿病协会制定了一种新颖的资助模式,通过其 Pathway to Stop Diabetes® 计划支持糖尿病研究。 Pathway 采取多方面的方法为糖尿病研究人员提供关键资金,以推进以理解、管理和治疗糖尿病各个方面为中心的广泛研究项目。本文提供了 2019 年 Pathway Accelerator 获奖者的个人观点,描述了一项研究项目,该项目旨在推进以材料为中心的方法来设计葡萄糖响应设备和新的输送工具,以实现更好的糖尿病治疗效果。在此同时提供对 ADA 衔接计划五年支持的个人反思。
更新日期:2024-04-12
down
wechat
bug